< Back to latest news & events

Retail Scanner

Tesco v Lidl over “Clubcard Prices” logo

November 2022

Every ‘Lidl’ Helps / Big on Quality, ‘Tesco’ on Price.

A decision of interest to the retail industry and retailers, but also to trade mark attorneys and lawyers on the everchanging topic of bad faith.

Lidl filed infringement proceedings against Tesco for their “Clubcard Prices” loyalty discount scheme which was launched in September 2022. Lidl claimed that the scheme, using a yellow circle on a blue square constituted infringement on the basis of the similarity with Lidl’s logo and that Tesco were attempting to “ride on [Lidl’s] coat-tails as a discount supermarket” by using the logo.

Tesco counterclaimed for invalidity and revocation of Lidl’s registration for its ‘wordless’ registration, which has never been used in the UK in the form registered, citing bad faith, as well as “evergreening” with Lidl refiling the wordless logo every 5 years to avoid non-use provisions.

In an interim decision, the High Court dismissed Tesco’s counterclaims on the basis that Tesco had not sufficiently substantiated their assertions and had not done enough to defeat a presumption of good faith. The judge assessed the case law on bad faith, including Sky v Skykick, noting that the trade mark system had to be used in a manner consistent with honest practices or acceptable commercial behavior with objective evidence and not merely inferences drawn from conduct that could otherwise be legitimate.

The Court of Appeal has now overturned the High Court decision, and allowed Tesco to pursue the bad faith actions and that their pleadings had a real prospect of success.

The case will now continue, with a full trial expected in 2023.

The case will be interesting for a number of reasons, not only in terms of the bad faith claims. The High Court decision also allowed Lidl to rely on survey evidence, which Tesco had criticised on the basis of its value and reliability, and provides a useful refresher on the case law on such evidence and how to assess its probative value. The court was of the opinion that under the Whitford guidelines, the survey results were likely to be of real value to the court in assessing recognition and distinctiveness, especially in instances where judges were not necessarily IP specialists.

It will also be interesting to see how the case is decided in respect of Lidl’s wordless mark in light of the earlier 2014 Specsavers case, where use of a mark with text was deemed to constitute use of the registered wordless mark.

So much to look forward to with this decision, so watch this space!

High Court decision here.

Court of Appeal decision here.


This article was prepared by HGF’s Trade Mark Director Claire Jones.

Latest updates

Happy World IP Day!

This year’s theme is ‘IP and the SDGs: Building our common future with innovation and creativity’. At HGF we are committed to supporting our clients in sustainable technologies and routinely …

Read article

IP Ingredients, Part 12: Exploring colours in the food & drink sector – overcoming hurdles and leveraging colour trade marks

We will all recognise as consumers an instance of when we used the colour of a product or its packaging to identify a specific brand that we wanted to buy …

Read article

Medical 3D Technologies: From Scanning to Printing

When we think of 3D technologies, we often think of 3D printing, which, as discussed later, has seen rapid advances in recent years. However, a sometimes overlooked area of medical …

Read article

Opinion Piece: Unitary Patent and Unified Patent Court in Ireland

Intellectual Property (IP) is a core part of any business and particularly is a vital part of the strategic toolkit for any business that creates value through innovation and constant …

Read article

IP Ingredients Blog, Parts 11-20

Welcome to our blog series, IP Ingredients, created by our Food & Drink Team. This blog will explore the latest IP news, updates, and discussions in the food & drink …

Read article

EnteroBiotix Limited Secures £27m Financing Round to Advance Clinical Trials

We are pleased to congratulate EnteroBiotix, on their milestone in their journey towards revolutionising healthcare for patients battling gut-related ailments. The leading clinical-stage biotechnology company has successfully closed a £27 …

Read article